Literature DB >> 4153459

Rapid induction of prolactin secretion by 3-iodo-L-tyrosine.

G A Smythe, J F Brandstater, L Lazarus.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4153459     DOI: 10.1159/000122281

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  5 in total

Review 1.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

2.  Catecholaminergic interactions in the regulation of thyrotropin (TSH) secretion in man.

Authors:  M F Scanlon; M D Rodriguez-Arnao; M Pourmand; D J Shale; D R Weightman; M Lewis; R Hall
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

3.  Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake, in acromegaly, in hyperprolactinaemia, and against stimulated prolactin release in man.

Authors:  M F Scanlon; A Gomez-Pan; B Mora; D B Cook; J H Dewar; A Hildyard; D R Weightman; D C Evered; R Hall
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335

Review 4.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

5.  Prolactin and thyrotropin response to blockade of dopamine synthesis by monoiodotyrosine in subjects with postpartum and pathological hyperprolactinemia.

Authors:  E Ghigo; E Ciccarelli; A Novelli; M Massobrio; E E Müller; F Camanni
Journal:  J Endocrinol Invest       Date:  1985-02       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.